SHE: 002864

Company Deals Hospital

Shaanxi Panlong Pharmaceutical Partners with Xi’an Medical University for Multifaceted Collaboration

Fineline Cube Jan 19, 2024

Shaanxi Panlong Pharmaceutical Group Co., Ltd (SHE: 002864), a leading pharmaceutical company based in China,...

Company Drug

Shaanxi Panlong Receives Patents for Coronavirus 3CL Protease Inhibitor

Fineline Cube Dec 22, 2022

China-based Shaanxi Panlong Pharmaceutical Group Co., Ltd (SHE: 002864) has announced receiving two patents (US11518759B1,...

Company Deals

Shaanxi Panlong Pharma Partners with Porton Pharma Solutions for Drug Development

Fineline Cube Dec 7, 2022

China-based Shaanxi Panlong Pharmaceutical Group Co., Ltd (SHE: 002864) announced a technology commission (development) agreement...

Company Drug

InnoCare’s Zurletrectinib Wins NMPA Nod as China’s First Next-Gen TRK Inhibitor

Company Deals

Brii Biosciences Taps OpenBench AI Platform to Accelerate Drug Discovery

Company Deals

GSK Terminates Ideaya Synthetic Lethality Partnership, Returns Two Clinical Programs

Company Deals

B&K Corporation Debuts on HKEX in $900M IPO Backed by Burn Drug Pipeline